CTOs on the Move

Metamark

www.metamarkgenetics.com

 
Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based, prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon, and breast cancers. In early 2014, Metamark plans to commercialize ProMark™—its prostate cancer prognostic test—through its Cambridge, Massachusetts CLIA-certified laboratory. For more information, please visit the company's Website at www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Coloplast

Coloplast is among the world’s leading suppliers of intimate healthcare products and services. As a group, we have built our current position by listening to consumers and understanding their needs. For more than 50 years, Coloplast has developed and marketed innovative products that make life easier for people with diseases of a personal and private nature. Our focus is centered on ostomy care, continence care, urology care and skin and wound care.

VNA Healthcare Partners of Ohio

VNA Healthcare Partners of Ohio is a Cleveland, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pyx Health

Pyx Health is leading the solution to Loneliness and Social Isolation through technology and human connection.

Infranco Moore Group

Infranco Moore Group is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Alliance Medical

Alliance Medical is a Russellville, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.